Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
39,039,096
-
Shares change
-
-1,391,200
-
Total reported value, excl. options
-
$396,249,329
-
Value change
-
-$15,719,655
-
Put/Call ratio
-
175%
-
Number of buys
-
45
-
Number of sells
-
-40
-
Price
-
$10.15
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q1 2020
117 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q1 2020.
Gossamer Bio, Inc. - Common Stock (GOSS) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,039,096 shares
of 227,306,614 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include HILLHOUSE CAPITAL ADVISORS, LTD. (5,911,541 shares), Omega Fund Management, LLC (4,275,726 shares), VANGUARD GROUP INC (3,812,267 shares), BlackRock Inc. (3,506,936 shares), Capital International Investors (3,275,851 shares), BOXER CAPITAL, LLC (2,185,000 shares), ALLIANCEBERNSTEIN L.P. (1,836,375 shares), Artal Group S.A. (1,808,968 shares), STATE STREET CORP (1,658,898 shares), and FEDERATED HERMES, INC. (1,517,200 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.